Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
19.57
+0.79 (4.21%)
Mar 31, 2026, 10:19 AM EDT - Market open
Hims & Hers Health Revenue
In the year 2025, Hims & Hers Health had annual revenue of $2.35B with 59.00% growth. Hims & Hers Health had revenue of $617.82M in the quarter ending December 31, 2025, with 28.41% growth.
Revenue (ttm)
$2.35B
Revenue Growth
+59.00%
P/S Ratio
1.82
Revenue / Employee
$961,358
Employees
2,442
Market Cap
4.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.35B | 871.12M | 59.00% |
| Dec 31, 2024 | 1.48B | 604.51M | 69.33% |
| Dec 31, 2023 | 872.00M | 345.08M | 65.49% |
| Dec 31, 2022 | 526.92M | 255.04M | 93.81% |
| Dec 31, 2021 | 271.88M | 123.12M | 82.77% |
| Dec 31, 2020 | 148.76M | 66.20M | 80.18% |
| Dec 31, 2019 | 82.56M | 55.88M | 209.45% |
| Dec 31, 2018 | 26.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch Health Companies | 10.27B |
| Amneal Pharmaceuticals | 3.02B |
| Lantheus Holdings | 1.54B |
| Alkermes | 1.48B |
| Phibro Animal Health | 1.46B |
| Prestige Consumer Healthcare | 1.10B |
| BioCryst Pharmaceuticals | 874.84M |
| Supernus Pharmaceuticals | 718.95M |
HIMS News
- 4 days ago - Hims & Hers: The Reset Before The Next Inflection - Seeking Alpha
- 4 days ago - Novo Nordisk's FDA-Approved GLP-1s Now Available With Hims & Hers - Business Wire
- 5 days ago - Hims & Hers: Distressed Valuations Will Not Last For Long - Seeking Alpha
- 5 days ago - HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewsWire
- 10 days ago - Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMS - PRNewsWire
- 13 days ago - UnitedHealth, Hims & Hers, Gambling.Com - Value Investing With Raul Shah - Seeking Alpha
- 17 days ago - OWL, HIMS, TSLA And More: 5 Stocks Investors Couldn't Stop Buzzing About This Week - Benzinga
- 18 days ago - Royce Smaller-Companies Growth Fund FY 2025: What Worked - Seeking Alpha